Atlas Trials

A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer

Clinical trial NCT01526369 · COMPLETED

Trial details

NCT number
NCT01526369
Sponsor
Cancer Trials Ireland
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2012-02-13
Primary completion
2015-11-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.